9-21975018-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_058195.4(CDKN2A):​c.194-3810G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.598 in 1,380,732 control chromosomes in the GnomAD database, including 252,742 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.50 ( 21585 hom., cov: 32)
Exomes 𝑓: 0.61 ( 231157 hom. )

Consequence

CDKN2A
NM_058195.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:3O:1

Conservation

PhyloP100: -0.170
Variant links:
Genes affected
CDKN2A (HGNC:1787): (cyclin dependent kinase inhibitor 2A) This gene generates several transcript variants which differ in their first exons. At least three alternatively spliced variants encoding distinct proteins have been reported, two of which encode structurally related isoforms known to function as inhibitors of CDK4 kinase. The remaining transcript includes an alternate first exon located 20 Kb upstream of the remainder of the gene; this transcript contains an alternate open reading frame (ARF) that specifies a protein which is structurally unrelated to the products of the other variants. This ARF product functions as a stabilizer of the tumor suppressor protein p53 as it can interact with, and sequester, the E3 ubiquitin-protein ligase MDM2, a protein responsible for the degradation of p53. In spite of the structural and functional differences, the CDK inhibitor isoforms and the ARF product encoded by this gene, through the regulatory roles of CDK4 and p53 in cell cycle G1 progression, share a common functionality in cell cycle G1 control. This gene is frequently mutated or deleted in a wide variety of tumors, and is known to be an important tumor suppressor gene. [provided by RefSeq, Sep 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 9-21975018-C-T is Benign according to our data. Variant chr9-21975018-C-T is described in ClinVar as [Benign]. Clinvar id is 873184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.63 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN2ANM_058195.4 linkc.194-3810G>A intron_variant Intron 1 of 2 ENST00000579755.2 NP_478102.2 Q8N726-1
CDKN2ANM_000077.5 linkc.-191G>A upstream_gene_variant ENST00000304494.10 NP_000068.1 P42771-1K7PML8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN2AENST00000579755.2 linkc.194-3810G>A intron_variant Intron 1 of 2 1 NM_058195.4 ENSP00000462950.1 Q8N726-1
CDKN2AENST00000304494.10 linkc.-191G>A upstream_gene_variant 1 NM_000077.5 ENSP00000307101.5 P42771-1

Frequencies

GnomAD3 genomes
AF:
0.504
AC:
76522
AN:
151970
Hom.:
21594
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.233
Gnomad AMI
AF:
0.562
Gnomad AMR
AF:
0.476
Gnomad ASJ
AF:
0.582
Gnomad EAS
AF:
0.648
Gnomad SAS
AF:
0.617
Gnomad FIN
AF:
0.663
Gnomad MID
AF:
0.509
Gnomad NFE
AF:
0.626
Gnomad OTH
AF:
0.503
GnomAD4 exome
AF:
0.610
AC:
749192
AN:
1228644
Hom.:
231157
Cov.:
40
AF XY:
0.610
AC XY:
361760
AN XY:
593052
show subpopulations
Gnomad4 AFR exome
AF:
0.212
Gnomad4 AMR exome
AF:
0.454
Gnomad4 ASJ exome
AF:
0.579
Gnomad4 EAS exome
AF:
0.681
Gnomad4 SAS exome
AF:
0.617
Gnomad4 FIN exome
AF:
0.662
Gnomad4 NFE exome
AF:
0.619
Gnomad4 OTH exome
AF:
0.590
GnomAD4 genome
AF:
0.503
AC:
76522
AN:
152088
Hom.:
21585
Cov.:
32
AF XY:
0.508
AC XY:
37727
AN XY:
74326
show subpopulations
Gnomad4 AFR
AF:
0.232
Gnomad4 AMR
AF:
0.476
Gnomad4 ASJ
AF:
0.582
Gnomad4 EAS
AF:
0.648
Gnomad4 SAS
AF:
0.617
Gnomad4 FIN
AF:
0.663
Gnomad4 NFE
AF:
0.626
Gnomad4 OTH
AF:
0.500
Alfa
AF:
0.592
Hom.:
7136
Bravo
AF:
0.473
Asia WGS
AF:
0.584
AC:
2036
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jun 22, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Squamous cell lung carcinoma Uncertain:1
May 05, 2020
Faculté Pluridciplinaire Nador, Université Mohamed Premier
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing;in vivo

- -

Neoplasm Other:1
Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance: -
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
5.9
DANN
Benign
0.88

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3814960; hg19: chr9-21975017; COSMIC: COSV58720858; COSMIC: COSV58720858; API